The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Acetic acid 4-[2-(3,4-dichloro-benzylamino)-6-oxo-1,6-dihydro-purin-7-yl]-butyl ester ID: ALA182056
PubChem CID: 135546630
Max Phase: Preclinical
Molecular Formula: C18H19Cl2N5O3
Molecular Weight: 424.29
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CC(=O)OCCCCn1cnc2nc(NCc3ccc(Cl)c(Cl)c3)nc(O)c21
Standard InChI: InChI=1S/C18H19Cl2N5O3/c1-11(26)28-7-3-2-6-25-10-22-16-15(25)17(27)24-18(23-16)21-9-12-4-5-13(19)14(20)8-12/h4-5,8,10H,2-3,6-7,9H2,1H3,(H2,21,23,24,27)
Standard InChI Key: JCUXVGVPNZXYOG-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 30 0 0 0 0 0 0 0 0999 V2000
0.0792 0.4333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6333 0.0208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7917 0.0000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.6333 -0.8167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0792 -1.2167 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.0958 1.2333 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.7917 -0.8167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2458 0.5583 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.9083 1.3000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1667 -0.5042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5042 -1.2167 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.3458 -1.2167 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-5.3208 1.8583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5792 -1.2167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3417 -0.5167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.0708 2.6458 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.1667 -1.9417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9417 -1.2167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5792 0.2000 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
2.2167 -0.8167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4042 -1.2167 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
3.3417 -1.9417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.7708 1.2583 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.0458 0.3833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.1250 1.6833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9583 1.4333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5958 0.9958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.4083 0.8208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 1 2 0
4 2 2 0
5 7 2 0
6 1 1 0
7 3 1 0
8 2 1 0
9 6 2 0
10 15 2 0
11 7 1 0
12 4 1 0
13 23 1 0
14 17 2 0
15 18 1 0
16 13 2 0
17 22 1 0
18 20 1 0
19 10 1 0
20 11 1 0
21 14 1 0
22 18 2 0
23 26 1 0
24 8 1 0
25 13 1 0
26 28 1 0
27 24 1 0
28 27 1 0
9 8 1 0
5 4 1 0
14 10 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 424.29Molecular Weight (Monoisotopic): 423.0865AlogP: 3.79#Rotatable Bonds: 8Polar Surface Area: 102.16Molecular Species: NEUTRALHBA: 8HBD: 2#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 12.33CX Basic pKa: 2.00CX LogP: 3.59CX LogD: 3.59Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.42Np Likeness Score: -1.14
References 1. Wright GE, Brown NC, Xu WC, Long ZY, Zhi C, Gambino JJ, Barnes MH, Butler MM.. (2005) Active site directed inhibitors of replication-specific bacterial DNA polymerases., 15 (3): [PMID:15664846 ] [10.1016/j.bmcl.2004.11.016 ]